PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. (2010)

First Author: McCormack S
Attributed to:  Mwanza Intervention Trials Facility funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/S0140-6736(10)61086-0

PubMed Identifier: 20851460

Publication URI: http://europepmc.org/abstract/MED/20851460

Type: Journal Article/Review

Volume: 376

Parent Publication: Lancet (London, England)

Issue: 9749

ISSN: 0140-6736